Author

F. Tabaro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:statistical model· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

F. Quaglia· 2 shared G. Minervini· 2 shared M. Nykter· 2 shared S. C. E. Tosatto· 2 shared A. Aakula· 1 shared A. Lussana· 1 shared A. Shcherban· 1 shared A. Urbanucci· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

F. Quaglia

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

RAS and PP2A activities converge on epigenetic gene regulation

A. Aakula, M. Sharma, F. Tabaro, H. Honkanen, M. Schapira, C. Arrowsmith, M. Nykter, J. Westermarck

This study identifies epigenetic gene regulation as a convergence point for RAS hyperactivity and PP2A inhibition in cancer, showing their co-regulation of key chromatin modifiers and oncogenic transcription.

bioRxiv · May 11, 2022Cancer Biology

Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression

J. Uusi-Mäkelä, E. Afyounian, F. Tabaro, T. Häkkinen, A. Lussana, A. Shcherban, M. Annala, R. Nurminen, K. Kivinummi, T. L. J. Tammela, A. Urbanucci, L. Latonen, J. Kesseli, K. J. Granberg, T. Visakorpi, M. Nykter

The paper analyzes chromatin accessibility in prostate cancer stages to identify regulatory elements and their role in gene expression changes during disease progression.

bioRxiv · Sep 8, 2020 · PreprintCancer Biology

Insights into the molecular features of the von Hippel-Lindau like protein

F. Quaglia, G. Minervini, F. Tabaro, S. C. E. Tosatto

This study characterizes the von Hippel-Lindau like protein (VLP) through in silico methods, showing its structural similarity to pVHL and potential functional overlap.

bioRxiv · Sep 3, 2018Cancer Biology

Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred from a Large-Scale Analysis of Disease Mutations and Interactors

G. Minervini, F. Quaglia, F. Tabaro, S. C. E. Tosatto

This paper analyzes VHL mutations and interactors to identify genotype-phenotype relationships and predict tumor transformation mechanisms.

bioRxiv · Aug 31, 2018Cancer Biology